nach oben

Erschienen in:

01.10.2009 | REVIEW

Inborn errors of metabolism and motor disturbances in children

verfasst von: A. García-Cazorla, N. I. Wolf, M. Serrano, B. Pérez-Dueñas, M. Pineda, J. Campistol, E. Fernández-Alvarez, J. Colomer, S. DiMauro, G. F. Hoffmann

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Summary

Motor disturbances are very common in paediatric neurology. Often families can be reassured that these are just variants of normal development. However, abnormal movements can also be the hallmark of severe brain dysfunction of different and complex origins. This review concentrates on motor disturbances as frequent and important symptoms of inborn errors of metabolism. A structured diagnostic approach is developed taking into account age-dependent physiological developments and pathophysiological responses of gross and fine motor functions. A series of investigations are presented with the primary aim of early diagnosis of treatable conditions. The correct recognition and differentiation of movement disorders (ataxia, rigid akinetic syndrome (‘parkinsonism’), dystonia, athetosis, tremor, and others), spasticity, and neuromuscular disorders, requires profound neurological expertise. A high level of suspicion and close interaction between paediatric neurologists and specialists in inborn errors of metabolism are indispensable to effectively and timely identify patients in whom motor disturbances are the presenting and/or main symptom of an inborn error.

Assmann B, Surtees R, Hoffmann GF (2003) Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia. Ann Neurol 54(Suppl 6):S18–24CrossRefPubMed

Baumgartner MR, Verhoeven NM, Jakobs C et al (1998) Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig–Hoffmann disease. Neurology. 51:1427–1432CrossRefPubMed

Bouillot S, Martin-Négrier ML, Vital A et al (2002) Peripheral neuropathy associated with mitochondrial disorders: 8 cases and review of the literature J Peripher Nerv Syst 7:213–220CrossRefPubMed

Buccoliero R, Palmeri S, Federico A (2003) Ataxia, myoclonus and macular degeneration. Orphanet. http://www.orpha.net/data/patho/GBuk-ataxiamyoclonus.pdf PubMed

Davidzon G, Greene P, Mancuso M et al (2006) Early-onset familial Parkinsonism due to POLG mutations. Ann Neurol 59:859–862CrossRefPubMed

Debray FG, Lambert M, Vanasse M et al (2006) Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency. Eur J Pediatr 165:462–466CrossRefPubMed

Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C. (2006) Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 142C:104–112CrossRefPubMed

Desnick RJ, Schindler D (2001) Alpha-N-acetylgalactosaminidase deficiency: Schindler disease. In: Scriver CR, Beaudet al Sly WS, Valle D (eds); Childs B, Kinzler KW, Vogelstein B (assoc. eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3483–3505

De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI (1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325(10):703–709CrossRefPubMed

Espinós C, Pineda M, Martínez-Rubio D (2009) Mutations in the urocanase gene UROC1 are associated with urocanic aciduria. J Med Genet (in press)

Fernández-Alvarez E, General concepts In: Fernández-Alvarez E, Aicardi J (eds) (2001) Movement disorders in children. MacKeith Press, London, pp 1–23

Garcia-Cazorla A, Rabier D, Touati G et al (2006) Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. Ann Neurol 59:121–127CrossRefPubMed

Gouider-Khouja N, Ben Youssef-Turki I (2006) [Type I glutaric aciduria: an unrecognized cause of progressive dystonia] Rev Neurol (Paris) 162(8–9):858–861CrossRef

Hakonen AH, Goffart S, Marjavaara S et al (2008) Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 17(23):3822–3835CrossRefPubMed

Hoffmann GF, Surtees RA, Wevers RA (1998) Cerebrospinal fluid investigations for neurometabolic disorders. Neuropediatrics 29:59–71CrossRefPubMed

Holmgren G, Brundin A, Gustavson KH, Sjögren S, Kleijer WJ, Niermeijer MF (1980) Intermittent neurological symptoms in a girl with a maple syrup urine disease (MSUD) variant. Neuropediatrics 11(4):377–383CrossRefPubMed

Homer VM, George PM, Du Toit S, Davidson JS, Wilson CJ (2005) Mental retardation and ataxia due to normotriglyceridemic hypobetalipoproteinemia. Ann Neurol 58:160–163CrossRefPubMed

Hyland K, Gibson KM, Sharma R, Van Hove JLK, Hoffmann GF (2009) Neurotransmitter disorders. In: Sarafoglu K, Hoffmann GF, Roth K (eds). Pediatric endocrinology and inborn errors of metabolism. McGraw-Hill, New York, pp 789–820

Jen JC (2008) Hereditary episodic ataxias. Ann N Y Acad Sci 1142:250–253CrossRefPubMed

Kleta R, Romeo E, Ristic Z et al (2004) Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet 36(9):999–1002CrossRefPubMed

Kurian MA, Morgan NV, MacPherson L et al (2008) Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene. Neurology 70(18):1623–1629CrossRefPubMed

Kurian MA, Zhen J, Cheng SY et al (2009) Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Invest 119(6):1595–1603PubMedPubMedCentral

Lacomis D, Roeske-Anderson L, Mathie L (2005) Neuropathy and Fabry’s disease. Muscle Nerve 31:102–107CrossRefPubMed

Lyon G, Fattal-Valevski A, Kolodny EH (2006) Leukodystrophies: clinical and genetic aspects. Top Magn Reson Imaging. 17:219–242CrossRefPubMed

Mariotti C, Gellera C, Rimolid M et al (2004) Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol Sci 25:130–137CrossRefPubMed

Marzouki N, Benomar A, Yahyaoui M et al (2005) Vitamin E deficiency ataxia with (744 del A) mutation on alpha-TTP gene: genetic and clinical peculiarities in Moroccan patients. Eur J Med Genet 48:21–28CrossRefPubMed

Mitchell G, Larochelle J, Lambert M et al (1990) Neurologic crises in hereditary tyrosinemia. N Engl J Med 322:432–437CrossRefPubMed

Morgan NV, Westaway SK, Morton JE et al (2006) PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 38:752–754CrossRefPubMedPubMedCentral

Moser H (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120:1485–1508CrossRefPubMed

Needham M, Duley J, Hammond S, Herkes GK, Hirano M, Sue CM (2007) Mitochondrial disease mimicking Charcot–Marie–Tooth disease. J Neurol Neurosurg Psychiatry 78:99–100CrossRefPubMedPubMedCentral

Oskoui M, Davidzon G, Pascual J et al (2006) Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol 63:1122–1126CrossRefPubMed

Overweg-Plandsoen WC, Groener JE et al (2003) GLUT-1 deficiency without epilepsy—an exceptional case. J Inherit Metab Dis 26:559–563CrossRefPubMed

Pons R, Andreetta F, Wang CH et al (1996) Mitochondrial myopathy simulating spinal muscular atrophy. Pediatr Neurol 15:153–158CrossRefPubMed

Poretti A, Wolf NI, Boltshauser E (2008) Differential diagnosis of cerebellar atrophy in childhood. Eur J Paediatr Neurol 12(3):155–167CrossRefPubMed

Prasad A, Greenberg C, Prasad C (2005) Ataxia with identified genetic and biochemical defects. (2005) Geneclinics. http://www.emedicine.com/neuro/topic556.htm. Accessed 25 July 2009.

Ramaekers VT, Brab M, Rau G, Heimann G (1993) Recovery from neurological deficits following biotin treatment in a biotinidase K _m variant. Neuropediatrics 24:98–102CrossRefPubMed

Ramaekers VT, Rothenberg SP, Sequeira JM et al (2005) Autoantibodies to folate receptor in the cerebral folate deficiency syndrome. N Engl J Med 352:1985–1991CrossRefPubMed

Robinson BH, MacKay N, Chun K, Ling M (1996) Disorders of pyruvate carboxylase and the pyruvate dehydrogenase complex. J Inherit Metab Dis 19(4):452–462CrossRefPubMed

Salvi S, Santorelli FM, Bertini E et al (2001) Clinical and molecular findings in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Neurology 57(5):911–914CrossRefPubMed

Saudubray JM, Martin D, de Lonlay P et al (1999) Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 22(4):488–502CrossRefPubMed

Scaglia F, Lee B (2006) Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency. Am J Med Genet C Semin Med Genet 142:113–120CrossRef

Schiffmann R, van der Knaap MS (2009) Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 72(8):750–759CrossRefPubMedPubMedCentral

Sedel F, Barnerias C, Dubourg O, Desguerres I, Lyon-Caen O, Saudubray JM (2007) Peripheral neuropathy and inborn errors of metabolism in adults. J Inherit Metab Dis 30:642–653CrossRefPubMed

Segawa M, Nomura Y, Nishiyama N (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease) Ann Neurol 54(Suppl 6):S32–45CrossRefPubMed

Siebner HR, Berndt S, Conrad B (1996) Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco–Sjoegren syndrome: a case report. J Neurol Neurosurg Psychiatry 60(5):582–585CrossRefPubMedPubMedCentral

Spiekerkoetter U, Bennett MJ, Ben-Zeev B, Strauss AW, Tein I (2004) Peripheral neuropathy, episodic myoglobinuria, and respiratory failure in deficiency of the mitochondrial trifunctional protein. Muscle Nerve 29:66–72CrossRefPubMed

Strauss KA, Morton DH, Puffenberger EG et al (2007) Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency. Mol Genet Metab 91(2):165–175CrossRefPubMed

Suls A, Dedeken P, Goffin K et al (2008) Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 131(Pt 7):1831–44CrossRefPubMedPubMedCentral

Surtees R (1998) Demyelination and inborn errors of the single carbon transfer pathway. Eur J Pediatr 157:S118–S121CrossRefPubMed

Surtees R, Leonard J, Austin S (1991) Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 338:8782–87831550–1554CrossRefPubMed

Tuschl K, Mills PB, Parsons H et al (2008) Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia—a new metabolic disorder. J Inherit Metab Dis 31(2):151–163CrossRefPubMed

Verrips A, Hoefsloot LH, Steen Bergen GC et al (2000) Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 123:908–919CrossRefPubMed

Wanders RJ (2004) Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol Genet Metab 83:16–27CrossRefPubMed

Wang D, Pascual JM, Yang H et al (2005) Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 57(1):111–118CrossRefPubMed

Titel: Inborn errors of metabolism and motor disturbances in children
verfasst von: A. García-Cazorla
N. I. Wolf
M. Serrano
B. Pérez-Dueñas
M. Pineda
J. Campistol
E. Fernández-Alvarez
J. Colomer
S. DiMauro
G. F. Hoffmann
Publikationsdatum: 01.10.2009
Verlag: Springer Netherlands
Erschienen in: Journal of Inherited Metabolic Disease / Ausgabe 5/2009
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-009-1194-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Bildnachweise

Die Leitlinien für Ärztinnen und Ärzte, Digitale Mammographien links in kraniokaudaler Projektion./© Weigel, S. et al. / all rights reserved Springer Medizin Verlag GmbH, Operation bei Blasenkrebs/© anistidesign / Fotolia, Medizinische Fachangestellte sitzt erschöpft auf der Treppe/© Courtney Haas / peopleimages.com /stock.adobe.com (Symbolbild mit Fotomodell), Mann wird von Ärztin untersucht/© Tashi-Delek, Getty Images, iStock (Symbolbild mit Fotomodellen)

Springer Medizin

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2009

Neurometabolic disorders

Mental retardation and inborn errors of metabolism

Epilepsy and inborn errors of metabolism in children

Total oxidant-scavenging capacities of plasma from glycogen storage disease type Ia patients as measured by cyclic voltammetry, FRAP and luminescence techniques

Glyceryl triacetate for Canavan disease: A low-dose trial in infants and evaluation of a higher dose for toxicity in the tremor rat model

Retinal detachment causing unilateral blindness in a 12-year-old girl with gyrate atrophy